TSCO
25
-8
FAST
34
-3
KIM
56
12
MLM
34
2
ORLY
45
-3
DIS
68
2
FOXA
62
-4
EMC
56
8
SE
57
2
XRX
46
2
DRI
69
19
SBUX
31
2
TDC
67
2
HST
49
2
WBA
38
-2
ES
9
2
V
56
8
CNP
42
4
HD
35
-3
GOOGL
56
-2
TSCO
25
-8
FAST
34
-3
KIM
56
12
MLM
34
2
ORLY
45
-3
DIS
68
2
FOXA
62
-4
EMC
56
8
SE
57
2
XRX
46
2
DRI
69
19
SBUX
31
2
TDC
67
2
HST
49
2
WBA
38
-2
ES
9
2
V
56
8
CNP
42
4
HD
35
-3
GOOGL
56
-2
Financhill
Back

Greenlight Capital Re Vs. Viking Therapeutics Industry Stock Comparison

Buy
59

GLRE
Greenlight Capital Re

Last Price:
$13.88
Seasonality Move:
0.62%
Sell
19

VKTX
Viking Therapeutics

Last Price:
$41.48
Seasonality Move:
40.87%
Buy
59
Greenlight Capital Re (GLRE) is a Buy

Is Greenlight Capital Re a Buy, Sell or Hold?

  • The current Greenlight Capital Re [GLRE] share price is $13.90. The Score for GLRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • GLRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $41.49. The Score for VKTX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GLRE Stock Price Chart

What is Greenlight Capital Re's stock price today?

  • The Greenlight Capital Re share price today is $13.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLRE is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $41.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

GLRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 30.72 Sell
Chaikin Money Flow: -38384 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.43 - 15.07) Sell
Bollinger Bands (100): (13.22 - 14.62) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.1 Sell
Relative Strength Index (14 RSI): 32 Sell
Chaikin Money Flow: 6081687 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.09 - 53.27) Sell
Bollinger Bands (100): (51.8 - 67.18) Sell

GLRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.51 Sell
20-day SMA: 14.79 Sell
50-day SMA: 14.33 Sell
200-day SMA: 13.3 Buy
8-day EMA: 14.39 Sell
20-day EMA: 14.58 Sell
50-day EMA: 14.39 Sell
200-day EMA: 13.34 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.71 Sell
20-day SMA: 49.34 Sell
50-day SMA: 58.17 Sell
200-day SMA: 62 Sell
8-day EMA: 45.01 Sell
20-day EMA: 49.06 Sell
50-day EMA: 54.7 Sell
200-day EMA: 54.48 Sell

Greenlight Capital Re Earnings Growth & GLRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.

Greenlight Capital Re Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):